| Combined Effects of Itraconazole and CYP2D6*10 Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Haloperidol in Healthy Subjects | 2006-04-25 |
| Inhibitory effects of fruit juices on cyp3a activity. | 2006-04-11 |
| Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba. | 2006-04-11 |
| In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomes. | 2006-04-11 |
| Photodegradation of bistrifluron in aqueous acetonitrile solution by UV irradiation. | 2006-04-11 |
| In Vitro Metabolism of a New Cardioprotective Agent, KR-33028 in the Human Liver Microsomes and Cryopreserved Human Hepatocytes | 2006-04-11 |
| The Prevalence of Hyperprolactinemia After Long-term Haloperidol Use in Patients With Chronic Schizophrenia | 2006-04-11 |
| Identification of flavonoids using liquid chromatography with electrospray ionization and ion trap tandem mass spectrometry with an MS/MS library. | 2006-04-11 |
| High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. | 2006-04-11 |
| Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression. | 2006-04-11 |
| Subunit composition of ATP-sensitive potassium channels in mitochondria of rat hearts. | 2006-04-11 |
| Tissue microarrays: bridging the gap between research and the clinic. | 2006-04-11 |
| Identification of Rat Urinary and Fecal Metabolites of a New Herbicide, Pyribenzoxim | 2006-04-11 |
| Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism | 2006-04-11 |
| Diclofenac attenuates Wnt/b-catenin signaling in colon cancer cells by activation of NF-kB | 2006-04-11 |
| MDR1 Genetic Polymorphisms and Comparison of MDR1 Haplotype Profiles in Korean and Vietnameses Populations | 2006-04-11 |
| Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but by CYP2C19 genetic polymorphism | 2006-04-11 |
| Genetic Polymorphism of CYP2C9 in a Vietnamese Kinh Population | 2006-04-11 |
| Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro | 2006-04-11 |
| Identification of functional characterization of nover CYP2J2 variants: G312 variant cuases loss of enzyme catalytic activity | 2006-04-11 |
| Lansoprazole enantiomer activates human liver microsomal SYP2C9 catalytic activity in a stereospecific and substrate-specific manner | 2006-04-11 |
| Analysis of the benidipine enantiomers in human plasma by liquid chromatography-mass spectrometry using a macrocyclic antibiotic (Vancomycin) chiral stationary phase column | 2006-04-11 |
| Simple and Sensitive Assay of Torasemide in Human Plasma by High-Performance Liquid Chromatography Using a Monolithic Silica Column | 2006-04-11 |
| Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry | 2006-04-11 |
| Effect of ketoconazole on the pharmacokinetics of resiglitazone in healthy subjects | 2006-04-11 |
| Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells | 2006-04-11 |
| Molecular determination of origin of acephalic cysticercosis | 2006-04-11 |
| Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion | 2006-04-11 |
| Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states | 2006-04-11 |
| Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes | 2006-04-11 |